Public-Private Partnerships Create Opportunity To Engage China In Global Health Security

Forbes: China’s Contribution To Global Health Security Through Pharma Partnerships
Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations and professor at Seton Hall University’s School of Diplomacy and International Relations

“…[A] public-private partnership (PPP) can offer an integrated and systematic approach to the development and purchase of needed vaccines, drugs, and therapies for public health challenges. … While PPP is increasingly becoming a buzz word in the Chinese economy, pharmaceutical PPPs remain largely alien in China’s new drug development. … Despite this, private foundations and international NGOs have forged partnerships with Chinese state-owned enterprises in R&D. … Relying on PPPs to deal with global health security threats has its own drawbacks. … Still, PPPs offer an important means to engage China to contribute to global health security in an efficient and effective manner” (3/22).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.